Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Chimerix Inc (NASDAQ: NASDAQ:CMRX) stock has reached a new 52-week high, touching $4.22 in recent trading, giving the company a market capitalization of $375 million. According to InvestingPro data, ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

Oklahoma’s 60th regular legislative session begins next week. And while lawmakers have filed more legislation than ever ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on DHR stock, giving a Buy rating yesterday.Invest with Confidence: ...

OppFi, Corcept Therapeutics, DXP Enterprises, Perpetua Resources and Graham are part of the Zacks Screen of the Week article.

The U.S. Food and Drug Administration (FDA) has taken a crucial step to protect public health: it has banned the use of Red Dye No. 3 in all food products. This synthetic dye, known for giving a ...

Nvidia's CEO lays out his vision of what the next 10 years will look like — and his simple advice to young people "I Have ...

Group scrutinizes cyber charter spending on cars, dining and entertainment” ( Jan. 29) should disgust each one of us. There’s a lack of oversight or accountability for these schools. Giving taxpayer ...

Officials previously argued that all 32 severance agreements were exempt as confidential personnel records under Virginia's ...

The small Oregon city at the heart of a major U.S. Supreme Court ruling last year that allowed cities across the country to ...

Food fraud and mislabeling harms consumer trust and… Coca-Cola has recalled a variety of soft drinks from 10 countries because of chemical contamination. Coca‑Cola Europacific Partners said ...